Connect with us

Business

Recall Widens for Diabetes Drug Metformin – WebMD

The FDA has been investigating the presence of nitrosamines, known to be a possible carcinogen, in the popular diabetes medications since December, when it was …

Published

on

post featured image

Oct. 12, 2020 The recall of extended-release metformin continues this month as 76 more lots have been flagged for a possible cancer-causing ingredient.
The FDA announced the latest recall, involving Marksans Pharma Limited and Sun Pharmaceutical Industries products, on Oct. 5. It involves the 500mg and 700mg tablets. More than 175 different drug combinations have been recalled since late May.
Consumers can see all the recalled metformin products at this FDA website. The agency says that immedi…

Click here to view the original article.